Correlation Between Acrivon Therapeutics, and Abcam PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Abcam PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Abcam PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Abcam PLC, you can compare the effects of market volatilities on Acrivon Therapeutics, and Abcam PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Abcam PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Abcam PLC.

Diversification Opportunities for Acrivon Therapeutics, and Abcam PLC

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Acrivon and Abcam is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Abcam PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcam PLC and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Abcam PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcam PLC has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Abcam PLC go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and Abcam PLC

Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 3.63 times less return on investment than Abcam PLC. In addition to that, Acrivon Therapeutics, is 1.74 times more volatile than Abcam PLC. It trades about 0.02 of its total potential returns per unit of risk. Abcam PLC is currently generating about 0.1 per unit of volatility. If you would invest  1,567  in Abcam PLC on September 3, 2024 and sell it today you would earn a total of  792.00  from holding Abcam PLC or generate 50.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy28.0%
ValuesDaily Returns

Acrivon Therapeutics, Common  vs.  Abcam PLC

 Performance 
       Timeline  
Acrivon Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Acrivon Therapeutics, is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Abcam PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abcam PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Abcam PLC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Acrivon Therapeutics, and Abcam PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acrivon Therapeutics, and Abcam PLC

The main advantage of trading using opposite Acrivon Therapeutics, and Abcam PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Abcam PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcam PLC will offset losses from the drop in Abcam PLC's long position.
The idea behind Acrivon Therapeutics, Common and Abcam PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories